Background & Aims
Persistent sympathetic nervous system activation (PSA – activation of the fight/flight/freeze system) is emerging as a significant contributor to chronic overlapping pain conditions such as migraine headache and chronic post-infectious disorders such as post-acute sequelae of SARS-COV-2 (Long-COVID). We hypothesized that individuals with pre-existing PSA, as evidenced by pre-existing migraine prior to a COVID infection, would have higher rates of Long-COVID symptoms after excluding patients with pre-existing fatigue.
Methods
TriNetX is a global health research network that facilitates deidentified data queries of healthcare records for over 117 million people in the world. We queried TriNetX for subjects with a history of COVID infection, with and without long-COVID (defined as new fatigue symptoms lasting ?1 month post-infection) and compared rates of pre-infection migraine diagnoses present in the 4 years prior to Covid infection in both groups.
We utilized the following codes for Long Covid: ICD 10 codes: UO7.1; UO7.2; J12.82 as well as TNX Curated 9088; LOINC 94500-6 and 94309-2 and the following for “fatigue” 1 month after the infection and without fatigue prior (ICD 10 codes R53 and G93.3).
Results
~4.0 million (3.8%) patients had a COVID infection and 2.9 million (2.7%) had a pre-existing history of migraine. Of the 173,000 patients with Long-COVID (4% of the COVID-infected population), 17,000 (9.8%) had a prior migraine diagnosis, compared to 164,000 (3.9%) of those without long-COVID (Chi-squared p <0.00001). In addition, new onset migraine after Covid infection occurred in 7,651 subjects (4.3%) in the Long Covid group, compared to ~51,000 of those in the short Covid group (1.2%) p<0.00001.
Conclusions
These preliminary findings are consistent with the hypothesis that PSA brought on by a pre-existing migraine diagnosis may increase Long-COVID risk, and may suggest new targets for Long-COVID prevention or treatment. Future studies should more rigorously examine the role of chronic pain and other PSA syndromes (fibromyalgia, chronic fatigue, irritable bowel syndrome, postural tachycardia syndrome) as a predisposing factor in Long-COVID.
References
1. Previous History of Migraine Is Associated With Fatigue, but Not Headache, as Long-Term Post-COVID Symptom After Severe Acute Respiratory SARS-CoV-2 Infection: A Case-Control Study.
Fernández-de-Las-Peñas C, Gómez-Mayordomo V, García-Azorín D, Palacios-Ceña D, Florencio LL, Guerrero AL, Hernández-Barrera V, Cuadrado ML.
Front Hum Neurosci. 2021 Jun 28;15:678472. doi: 10.3389/fnhum.2021.678472. eCollection 2021.
PMID: 34295230
2. Episodic Migraine and POTS. Mueller B.
Curr Pain Headache Rep. 2023 Nov;27(11):757-763. doi: 10.1007/s11916-023-01173-8. Epub 2023 Oct 7.
PMID: 37804458
3. Changes in MIDAS, Perceived Stress, Frontalis Muscle Activity and Non-Steroidal Anti-Inflammatory Drugs Usage in Patients with Migraine Headache without Aura following Ayurveda and Yoga Compared to Controls: An Open Labeled Non-Randomized Study.
Vasudha MS, Manjunath NK, Nagendra HR.
Ann Neurosci. 2018 Dec;25(4):250-260. doi: 10.1159/000492269. Epub 2018 Sep 11.
PMID: 31000965
4. World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. World Health Organization. Accessed August 2, 2022. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
Presenting Author
Gisela Chelimsky
Poster Authors
Gisela Chelimsky
Dr. med.
Virginia Commonwealth University
Lead Author
Patrick Shi
Virginia Commonwealth University
Lead Author
Patricia Kinser
Virginia Commonwealth University
Lead Author
James Burch
Virginia Commonwealth University
Lead Author
Raouf Gharbo
DO
Virginia Commonwealth University School of Medicine
Lead Author
Thomas Chelimsky
MD
Lead Author
Topics
- Epidemiology